Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IMATINIB vs TICAGRELOR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IMATINIB vs TICAGRELOR: Safety Overview

Metric IMATINIB TICAGRELOR
Total FAERS Reports 43,161 22,885
Deaths Reported 13,761 2,951
Death Rate 31.9% 12.9%
Hospitalizations 7,264 8,579
Average Patient Age 55.7 yrs 65.9 yrs
% Female Patients 47.2% 36.7%
FDA Approval Date Apr 14, 2025 Apr 21, 2023
Manufacturer Dr.Reddy's Laboratories Inc Mylan Pharmaceuticals Inc.
Route ORAL ORAL
Marketing Status Discontinued Prescription